(Q80860253)
Statements
Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I (English)
Johann Bauersachs
Felix Fleissner
Ivonne Klink
Dimitrios Tsikas
Marten Jakob
Dirk O Stichtenoth